Abstract
A Phase 1/2a Open-Label Study to Investigate the Safety of the Transplantation (by Injection) of Human Glial Restricted Progenitor Cells (hGRPs; Q-Cells®) into Subjects with Transverse Myelitis (TM) (P1.2-020)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have